Monoinfection with either hepatitis B (HBV) or C virus (HCV) represents one of the major
causes of chronic liver disease globally. However, in endemic areas a substantial number of …

Hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection is a complex clinical entity
that has an estimated worldwide prevalence of 1–15%. Most clinical studies have shown …

Worldwide, some 240 million people have chronic hepatitis B virus (HBV), with the highest
rates of infection in Africa and Asia. Our understanding of the natural history of HBV infection …

Chronic hepatitis B is one of the leading causes of hepatocellular carcinoma (HCC)
worldwide. Accurate prediction of HCC risk is important for decisions on antiviral therapy …

Insulin-like Growth Factor (IGF)/IGF-1 Receptor (IGF-1R) signaling is known to regulate stem
cell pluripotency and differentiation to trigger cell proliferation, organ development, and …

Human immunodeficiency virus, hepatitis B virus, and hepatitis C virus are three blood-
borne viruses that can cause major global health issues by increasing severe morbidity …

The experts of Taiwan Association for the Study of Liver (TASL) have actively participated
and led the guidelines on hepatitis B virus (HBV) management by Asian Pacific Association …

Hepatitis C virus (HCV) and hepatitis B virus (HBV) co-infection can be encountered in either
virus endemic countries. Co-infection can also be found in populations at risk of parenteral …

Background Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related
mortality in Taiwan. To help clinical physicians to manage patients with HCC, the Taiwan …

In endemic areas, hepatitis C virus (HCV)/hepatitis B virus (HBV) coinfection is common, and
patients with coinfection have a higher risk of developing liver disease such as …